Search

Danyal Haider

Examiner (ID: 6723)

Most Active Art Unit
4144
Art Unit(s)
4144
Total Applications
1
Issued Applications
0
Pending Applications
0
Abandoned Applications
1

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18877472 [patent_doc_number] => 20240000841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM [patent_app_type] => utility [patent_app_number] => 18/312330 [patent_app_country] => US [patent_app_date] => 2023-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312330 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/312330
LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM May 3, 2023 Pending
Array ( [id] => 19060193 [patent_doc_number] => 11939402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-26 [patent_title] => Antifungal peptides, compounds including the same, and methods of use thereof [patent_app_type] => utility [patent_app_number] => 18/128062 [patent_app_country] => US [patent_app_date] => 2023-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 8788 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128062 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/128062
Antifungal peptides, compounds including the same, and methods of use thereof Mar 28, 2023 Issued
Array ( [id] => 18628232 [patent_doc_number] => 20230287085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => COLLAGEN FIBER-BASED INK AND METHODS OF USE FOR BIOPRINTING [patent_app_type] => utility [patent_app_number] => 18/173506 [patent_app_country] => US [patent_app_date] => 2023-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173506 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/173506
COLLAGEN FIBER-BASED INK AND METHODS OF USE FOR BIOPRINTING Feb 22, 2023 Pending
Array ( [id] => 18879086 [patent_doc_number] => 20240002455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => CHILI PEPPER SEED ISOLATED OLIGOPEPTIDE FTLE AND APPLICATION THEREOF IN PREVENTING OR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 18/169149 [patent_app_country] => US [patent_app_date] => 2023-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2916 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169149 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/169149
Chili pepper seed isolated oligopeptide FTLE and application thereof in preventing or treating cancer Feb 13, 2023 Issued
Array ( [id] => 18628203 [patent_doc_number] => 20230287052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => PEPTIDE COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/159021 [patent_app_country] => US [patent_app_date] => 2023-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20393 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159021 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/159021
PEPTIDE COMPOSITIONS AND METHODS OF USE Jan 23, 2023 Pending
Array ( [id] => 18725848 [patent_doc_number] => 20230340074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS [patent_app_type] => utility [patent_app_number] => 18/150983 [patent_app_country] => US [patent_app_date] => 2023-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37433 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150983 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/150983
METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS Jan 5, 2023 Pending
Array ( [id] => 18497392 [patent_doc_number] => 20230220022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => HMGN PARTIAL PEPTIDE AND CANCER THERAPY USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/092737 [patent_app_country] => US [patent_app_date] => 2023-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15497 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18092737 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/092737
HMGN partial peptide and cancer therapy using the same Jan 2, 2023 Issued
Array ( [id] => 18673075 [patent_doc_number] => 20230310547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => USE OF SOLUBLE PRO(RENIN) RECEPTOR TO TREAT METABOLIC DISORDERS AND RELATED CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/145730 [patent_app_country] => US [patent_app_date] => 2022-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18557 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145730 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/145730
Use of soluble pro(renin) receptor to treat metabolic disorders and related conditions Dec 21, 2022 Issued
Array ( [id] => 19151381 [patent_doc_number] => 11976280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-07 [patent_title] => SMAC/Diablo inhibitors useful for treating cancer [patent_app_type] => utility [patent_app_number] => 18/063397 [patent_app_country] => US [patent_app_date] => 2022-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 89 [patent_no_of_words] => 34126 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063397 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/063397
SMAC/Diablo inhibitors useful for treating cancer Dec 7, 2022 Issued
Array ( [id] => 18829655 [patent_doc_number] => 20230398179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-14 [patent_title] => APPLICATION OF SKELETAL MUSCLE SECRETED FACTOR THBS4 IN PREPARATION OF DRUG FOR IMPROVING SYSTEMIC GLUCOSE AND LIPID METABOLISM [patent_app_type] => utility [patent_app_number] => 18/062028 [patent_app_country] => US [patent_app_date] => 2022-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2601 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062028 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/062028
Application of skeletal muscle secreted factor THBS4 in preparation of drug for improving systemic glucose and lipid metabolism Dec 5, 2022 Issued
Array ( [id] => 19256875 [patent_doc_number] => 12016904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF [patent_app_type] => utility [patent_app_number] => 18/062534 [patent_app_country] => US [patent_app_date] => 2022-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 63330 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062534 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/062534
Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF Dec 5, 2022 Issued
Array ( [id] => 18692557 [patent_doc_number] => 20230322855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => ANTI-ALLERGIC PEPTIDE AND USE THEREOF FOR IMMUNE REGULATION AND ANTI-ALLERGY [patent_app_type] => utility [patent_app_number] => 18/061238 [patent_app_country] => US [patent_app_date] => 2022-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6619 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061238 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/061238
ANTI-ALLERGIC PEPTIDE AND USE THEREOF FOR IMMUNE REGULATION AND ANTI-ALLERGY Dec 1, 2022 Pending
Array ( [id] => 19274435 [patent_doc_number] => 12024546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Peptides and anti-cancer compositions including thereof [patent_app_type] => utility [patent_app_number] => 18/070125 [patent_app_country] => US [patent_app_date] => 2022-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 96 [patent_no_of_words] => 14545 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070125 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/070125
Peptides and anti-cancer compositions including thereof Nov 27, 2022 Issued
Array ( [id] => 19410591 [patent_doc_number] => 12076383 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-03 [patent_title] => Compositions and methods for inducing humoral and cellular immunities against tumors and cancer [patent_app_type] => utility [patent_app_number] => 18/056843 [patent_app_country] => US [patent_app_date] => 2022-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 26924 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056843 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/056843
Compositions and methods for inducing humoral and cellular immunities against tumors and cancer Nov 17, 2022 Issued
Array ( [id] => 18451625 [patent_doc_number] => 20230192904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/057127 [patent_app_country] => US [patent_app_date] => 2022-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57264 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057127 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/057127
BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF Nov 17, 2022 Pending
Array ( [id] => 18283964 [patent_doc_number] => 20230099436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => METHOD FOR PREPARING NATURAL BIOACTIVE PEPTIDE TUBULYSIN U [patent_app_type] => utility [patent_app_number] => 17/984642 [patent_app_country] => US [patent_app_date] => 2022-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6784 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 492 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984642 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/984642
Method for preparing natural bioactive peptide Tubulysin U Nov 9, 2022 Issued
Array ( [id] => 18647849 [patent_doc_number] => 20230293625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => Method for treating gingivitis and gingival atrophy and repairing oral mucosa [patent_app_type] => utility [patent_app_number] => 18/048025 [patent_app_country] => US [patent_app_date] => 2022-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2746 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048025 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/048025
Method for treating gingivitis and gingival atrophy and repairing oral mucosa Oct 18, 2022 Pending
Array ( [id] => 18449589 [patent_doc_number] => 20230190865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => VIP Antagonists and Uses in Treating Cancer [patent_app_type] => utility [patent_app_number] => 18/047135 [patent_app_country] => US [patent_app_date] => 2022-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12302 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047135 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/047135
VIP Antagonists and Uses in Treating Cancer Oct 16, 2022 Pending
Array ( [id] => 18322507 [patent_doc_number] => 20230120635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => Peptides and Fragments for Treating Diabetes and Associated Metabolic Diseases [patent_app_type] => utility [patent_app_number] => 17/963700 [patent_app_country] => US [patent_app_date] => 2022-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13396 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17963700 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/963700
Peptides and Fragments for Treating Diabetes and Associated Metabolic Diseases Oct 10, 2022 Pending
Array ( [id] => 18310051 [patent_doc_number] => 20230113951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => SYSTEMS AND METHODS OF TREATING PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 17/964023 [patent_app_country] => US [patent_app_date] => 2022-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3570 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17964023 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/964023
SYSTEMS AND METHODS OF TREATING PROSTATE CANCER Oct 10, 2022 Pending
Menu